Our Approach to Advanced Lung Disease
Montefiore Einstein Advanced Lung Disease Program provides comprehensive and multidisciplinary services, treatment and surgical options. We’re ranked in the top 1% of all hospitals in the nation for Pulmonology & Lung Surgery according to U.S. News & World Report. The program is the only provider of treatment for interstitial lung disease and advanced emphysema in the local community. We are also the only program in New York that offers transbronchial cryobiopsy for patients with interstitial lung disease.
As part of the Comprehensive Lung Program, our team of pulmonologists, thoracic surgeons, cardiothoracic surgeons, cardiologists specializing in pulmonary hypertension, radiologists, rheumatologists, and other related specialists come together to provide groundbreaking care.
Advanced Lung Disease Treatments
Bullectomy is a surgical procedure that removes diseased portions of the lungs.
Endobronchial therapies include treatment of endobronchial valves to correct airway leaks, endoscopic lung volume reduction, and insertion of tracheal and bronchial stents.
Our highly skilled physicians have expertise in the use of extracorporeal membrane oxygenation (ECMO), which uses a pump to circulate blood through an artificial lung that oxygenates the blood, providing a bridge for patients who might not otherwise survive long enough to receive a lung transplant.
In collaboration with the experts at Montefiore Einstein Comprehensive Cancer Center, our multidisciplinary team of surgeons and researchers work closely together to design a care plan personalized to each patient and their cancer journey.
Lung transplantation is a surgical procedure in which a patient’s diseased lungs are partially or totally replaced by lungs from an organ donor. Learn More
Lung volume reduction surgery (LVRS) is a surgical procedure that removes damaged lung tissue in patients with severe emphysema in order to improve the function of the remaining lung tissue.
This minimally invasive treatment is used to treat diaphragmatic paralysis, profound abnormalities of pulmonary and respiratory muscle function.
This minimally invasive procedure for the diagnosis of interstitial lung disease uses a cryoprobe, inserted through your nose and down your airway, to rapidly freeze and extract a lung tissue sample.
This state-of-the-art, minimally invasive thoracic surgery enables doctors to view the organs inside the chest to check for abnormal areas as well as to remove tissue or lymph node samples. Small incisions (cuts) are made between the ribs and a thoracoscope (a thin, tube-like instrument equipped with a light and a camera) is inserted into the chest, which provides the surgeon with a clear, magnified view of the area and ensures greater precision.
Our Care Support
The Montefiore Einstein Comprehensive Lung Program has a reputation for providing exemplary care and support, including hosting support groups for those with interstitial lung disease or patients considering a lung transplant. All of our support groups are conveniently accessible in person or online.
Your Advanced Lung Disease Team
Stephen J. Forest, MD
Ali Y. Mansour, MD
In addition to the program’s surgical and medical directors, the medical faculty is complemented by the renowned bronchology expertise of Drs. Ali Mansour and Samar Alsunaid. Dr. Mansour is board certified in pulmonary and critical care, critical care echocardiography, interventional pulmonology, vascular medicine, and sleep medicine. Dr. Alsunaid is board certified in pulmonary and critical care, as well as interventional pulmonology.
Conditions Our Specialists Treat
Our board-certified physicians are specially trained in the various stages and symptoms associated with each respiratory disease. Patients can receive the full range of lung function testing and consultation for surgery.
COPD is a lung disease that makes it difficult to breathe. It is caused by damage to the lungs over many years, usually caused by smoking.
Caused by scarring and blood clots, chronic thromboembolic pulmonary hypertension (CTEPH) occurs when there is high blood pressure in the small blood vessels of the lungs. CTEPH is treatable. However, if left untreated, patients with CTEPH have a reduced life expectancy.
Cystic fibrosis is a progressive, genetic disease that affects the lungs, pancreas and other organs. In the lungs, mucus clogs the airways and can lead to infections, inflammation, respiratory failure and other complications.
This is lung disease with infiltration of eosinophils, a type of white blood cell. Eosinophilic lung disease occurs as a reaction to infection, drugs, autoimmune disease or malignancy. Therapy depends on proper diagnosis of the cause, and early intervention will result in full recovery.
Caused by environmental exposure, genetics or lifestyle habits, interstitial lung disease (ILD) refers to a group of diseases that cause scarring (fibrosis) of the lungs. The scarring makes it difficult to breathe and get sufficient oxygen to the bloodstream. Lung damage from ILD is often irreversible and gets worse over time.
In people who have this rare lung disease, abnormal cells grow out of control in the lungs and other parts of the body, creating systems that can reduce or prevent airflow in and out of the lungs.
Bronchiectasis is a chronic condition where the walls of the bronchi are thickened from inflammation or infection, periodically causing difficulties with breathing. Treatment focuses on preventing infections and flare-ups through the use of medication, hydration and physical therapy.
This breathing disorder can affect some people who suffer from obesity and involves breathing at a slow rate, which can result in not enough oxygen and too much carbon dioxide in the body.
This terminology is used to refer to exceptionally rare lung diseases with little to no research or limited treatment options.
Pulmonary alveolar proteinosis is a rare lung disease that can clog the alveoli (air sacs) in your lungs, resulting in impaired effectiveness of breathing, reduced oxygen labels and other issues.
Pulmonary hypertension occurs when pressure in the blood vessels leading from the heart to the lungs is too high. This condition affects the arteries in the lungs and the right side of the heart.
This syndrome, often caused by autoimmune disease, describes combined respiratory and kidney failure with bleeding in the lungs.
Tracheomalacia is the collapse of the windpipe (trachea). This is most often seen in newborns when the cartilage of the windpipe has not fully developed or has been damaged.
Asthma is a chronic disease that makes it difficult to move air into and out of your lungs due to inflammation. There are many types of asthma, and it can be diagnosed at any time in one's life. This serious disease can often be managed through medications, treatments, and lifestyle changes.
Our Location
We serve all Comprehensive Lung Program patients under one unified team. This team approach ensures multifaceted care, minimizing complexity for patients and ensuring seamless communication.
Greene Medical Arts Pavilion
3400 Bainbridge Avenue, 5th Floor
Bronx, NY 10467
718-920-LUNG (5864)
